Influence of TLR-2 in the immune response in the infection induced by fungus Sporothrix schenckii

Immunological Investigations

Volumn 43, Issue 4, 2014, Pages 370-390

  Negrini, Thais De C ^a   Ferreira, Lucas S ^a   Arthur, Rodrigo A ^b   Alegranci, Pâmela ^a   Placeres, Marisa C P ^a   Spolidorio, Luis C ^a   Carlos, Iracilda Z ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cytokines; Mice; Sporothrix schenckii; Sporotrichosis; TLR 2

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; KNOCKOUT MOUSE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN WEIGHT; SPOROTRICHOSIS; WILD TYPE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; ORGAN SIZE; PATHOLOGY; SPLEEN; SPOROTHRIX;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NITRIC OXIDE; ORGAN SIZE; SPLEEN; SPOROTHRIX; SPOROTRICHOSIS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897986182     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.879174     Document Type: Article

References (61)

1. Akira S, Uematsu S, Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell, 124, 783-801. (Pubitemid 43261452)
2. Alegranci P, de Abreu Ribeiro LC, Ferreira LS, et al. (2013). The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Mycopathologia, 176, 57-65.
3. Barros MB, Schubach AO, Schubach TM, et al. (2008). An epidemic of sporotrichosis in Rio de Janeiro, Brazil: Epidemiological aspects of a series of cases. Epidemiol Infect, 136, 1192-6.
4. Bozza S, Zelante T, Moretti S, et al. (2008). Lack of Toll IL-1R8 Exacerbates Th17 cell responses in fungal infection. J Immunol, 180, 4022-31.
5. Braedel S, Radsak M, Einsele H, et al. (2004). Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol, 125, 392-9. (Pubitemid 38621772)
6. Bustamante B, Campos PE. (2001). Endemic sporothricosis. Curr Opin Infect Dis, 14, 145-9.
7. Carlos IZ, Sgarbi DBG, Santos GC, Placeres MCP. (2003). Sporothrix schenckii lipid inhibits macrophage phagocytosis, involvement of nitric oxide and tumor necrosis factor-a. Scand J Immunol, 57, 214-20. (Pubitemid 36356813)
8. Carlos IZ, Zini MM, Sgarbi DBG, et al. (1994). Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia, 127, 189-94. (Pubitemid 2164100)
9. Carlos IZ, Sgarbi DB, Angluster J, et al. (1992). Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia, 117, 139-44.
10. Chai LY, Vonk AG, Kullberg BJ, et al. (2011). Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses. Microbes Infect, 13, 151-9.
11. Chen Z, Tato CM, Muul L, et al. (2007). Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum, 56, 2936-46. (Pubitemid 47502740)
12. da Rosa AC, Scroferneker ML, Vettorato R, et al. (2005). Epidemiology of sporotrichosis: A study of 304 cases in Brazil. J Am Acad Dermatol, 52, 451-9.
13. Dusse LMS, Vieira LM, Carvalho MG. (2003). Revisão sobre óxido ńitrico. Jornal Brasileiro de Patologia e Medicina Laboratorial, 39, 343-50.
14. Ghoreschi K, Laurence A, Yang XP, et al. (2010). Generation of pathogenic T(H)17 cells in the absence of TGF-b signalling. Nature, 467, 967-71.
15. Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem, 126, 131-8. (Pubitemid 13203451)
16. Hardman S, Stephenson I, Jenkins DR, et al. (2005). Disseminated Sporothix schenckii in a patient with AIDS. J Infect, 51, 73-7.
17. Joshi A, Pancari G, Cope L, et al. (2012). Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum Vaccin Immunother, 8, 336-46.
18. Kauffman CA. (1999). Sporotrichosis. Clin Infect Dis, 29, 231-6.
19. Kawai T, Akira S. (2010). The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol, 11, 373-84.
20. Kawai T, Akira S. (2007). Signaling to NF-kB by Toll-like receptors. Trends Mol Med, 13, 460-9.
21. Kondo T, Kawai T, Akira S. (2012). Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol, 3, 449-58.
22. Korn T, Oukka M, Kuchroo V, Bettelli E. (2007). Th17 cells: Effector T cells with inflammatory properties. Semin Immunol, 19, 362-71. (Pubitemid 351274046)
23. Lee HJ, Cho JW, Kim SC, et al. (2006). Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-alpha-and dexamethasone-stimulated human periodontal ligament cells. Cytokine, 35, 67-76.
24. Li M, Chen Q, Sun J, et al. (2012). Inflammatory response of human keratinocytes triggered by Sporothrix schenckii via Toll-like receptor 2 and 4. J Dermatol Sci, 66, 80-2.
25. Lin Y, Slight SR, Khader SA. (2010). Th17 cytokines and vaccine-induced immunity. Semin Immunopathol, 32, 79-90.
26. Liu G, Zhang L, Zhao Y. (2010). Modulation of immune responses through direct activation of Toll-like receptors to T cells. Clin Exp Immunol, 160, 168-75.
27. Lopes-Bezerra LM, Schubach A, Costa RO. (2006). Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc, 78, 293-308. (Pubitemid 43764836)
28. Loures FV, Pina A, Felonato M, Calich VL. (2009). TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol, 183, 1279-90.
29. Maia DC, Sassá MF, Placeres MC, Carlos IZ. (2006). Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathologia, 161, 11-19. (Pubitemid 43042216)
30. Mangan PR, Harrington LE, O'Quinn DB, et al. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441, 231-34.
31. McGeachy MJ, McSorley SJ. (2012). Microbial-induced Th17: Superhero or super-villain? J Immunol, 189, 3285-91.
32. McGettrick AF, O'Neill LA. (2010). Localisation and trafficking of Toll-like receptors: An important mode of regulation. Curr Opin Immunol, 22, 20-7.
33. Meier A, Kirschning CJ, Nikolaus T, et al. (2003). Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol, 5, 561-70. (Pubitemid 36939595)
34. Mesquita Jr D, Cruvinel WM, Câmara NO, et al. (2009). Autoimmune diseases in the TH17 era. Braz J Med Biol Res, 42, 476-86.
35. Moseley TA, Haudenschild DR, Rose L, Reddi AH. (2003). Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 14, 155-74. (Pubitemid 36389528)
36. Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth, 65, 55-63. (Pubitemid 14203433)
37. Nakamura Y, Sato H, Watanabe S, et al. (1996). Sporothrix schenckii isolated from a cat in Japan. Mycoses, 39, 125-8. (Pubitemid 26226457)
38. Negrini TC, Ferreira LS, Arthur RA, et al. (2013). Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest, 42, 36-48.
39. Netea MG, Sutmuller R, Hermann C, et al. (2004). Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol, 172, 3712-8. (Pubitemid 38337955)
40. Netea MG, Van der Graaf CA, Vonk AG, et al. (2002). The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis, 185, 1483-9. (Pubitemid 34507972)
41. Ouyang W, Kolls JK, Zheng Y. (2008). The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity, 28, 454-67. (Pubitemid 351471762)
42. Ramos-E-Silva M, Vasconcelos C, Carneiro S, Cestari T. (2007). Sporotrichosis. Clin Dermatol, 25, 181-7. (Pubitemid 46389469)
43. Robinson KM, Manni ML, Biswas PS, Alcorn JF. (2013). Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep, 13, 587-95.
44. Romani L. (2004). Immunity to fungal infections. Nat Rev Immunol, 4, 1-23.
45. Romani L. (2011). Immunity to fungal infections. Nat Rev Immunol, 11, 275-88.
46. Sassá MF, Ferreira LS, Ribeiro LC, Carlos IZ. (2012). Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia, 174, 21-30.
47. Sassá MF, Saturi AE, Souza LF, et al. (2009). Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology, 128, 301-9.
48. Schubach A, Barros MB, Wanke B. (2008). Epidemic sporotrichosis. Curr Opin Infect Dis, 21, 129-33. (Pubitemid 351641514)
49. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. (2003). Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol, 21, 713-58. (Pubitemid 37174546)
50. Takeda K, Akira S. (2005). Toll-like receptors in innate immunity. Int Immunol, 17, 1-14.
51. Takeda K, Kaisho T, Akira S. (2003). Toll-like receptors. Annu Rev Immunol, 21, 335-76. (Pubitemid 37174535)
52. Torre D, Speranza F, Martegani R. (2002). Role of proinflammatory and anti-inflammatory cytokines in the immune response to Plasmodium falciparum malaria. Lancet Infect Dis, 2, 719-20. (Pubitemid 35434556)
53. Underhill DM, Ozinsky A. (2002). Phagocytosis of microbes: Complexity in action. Annu Rev Immunol, 20, 825-52. (Pubitemid 34293441)
54. Underhill DM, Ozinsky A, Hajjar AM, et al. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 401, 811-5.
55. Villamón E, Gozalbo D, Roig P, et al. (2004a). Toll-like receptor-2 is essential in murine defensas against Candida albicans infections. Microbes Infect, 6, 1-7. (Pubitemid 38114815)
56. Villamón E, Gozalbo D, Roig P, et al. (2004b). Toll-like receptor-2 is dispensable for acquired host immune resistance to Candida albicans in a murine model disseminated candidiasis. Microbes Infect, 6, 542-8. (Pubitemid 38680595)
57. Volpe E, Servant N, Zollinger R, et al. (2008). A critical function for transforming growth factor-b, interleukin-23 and proinflammatory cytokines in driving and modulating human Th17 responses. Nat Immunol, 9, 65-7.
58. Weaver CT, Harrington LE, Mangan PR, et al. (2006). Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity, 24, 677-88. (Pubitemid 43867371)
59. Weaver CT, Hatton RD, Mangan PR, Harrington LE. (2007). IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol, 25, 821-52. (Pubitemid 46697925)
60. Wing JB, Sakaguchi S. (2012). Multiple treg suppressive modules and their adaptability. Front Immunol, 3, 178. doi: 10.3389/fimmu.2012.00178.eCollection 2012.
61. Ye P, Rodriguez FH, Kanaly S, et al. (2001). Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med, 194, 519-27. (Pubitemid 32835046)